Seeing No End to Crisis in Sight, Soros Shorts World
George Soros doesn't see anything that even remotely resembles his idea of what's needed to jumpstart economic recovery and so still can't see the bottom. There's perhaps no one in the world at spotting the opportunities that emerge when political orthodoxy conflict with financial reality than Soros--so much. After the jump, a look into the SEC filings of his Soros Management, which provide a window into his vision of the future (well, due to filing cycles, as he saw the future last quarter).
Some of Soros's notable positions include stakes in Best Buy and Merrill Lynch--positions that foresaw Circuit City's demise amidst deteriorating and Merrill's comparatively rich takeover by Bank of America. His two largest holdings traded on U.S. exchanges, however, are in Potash, a Canadian crop nutrients producers, and Petrobras, Brazil's national oil company. Imagine a looming surge in oil prices in the face of diminishing supply and a rush to cultivate agricultural alternatives --George Soros has.
Antimicrobial resistance is growing worldwide, rendering many "work horse" medicines ineffective. Without intervention, drug-resistant pathogens could lead to millions of deaths by 2050. Thankfully, companies like Pfizer are taking action.
- Antimicrobial-resistant pathogens are one of the largest threats to global health today.
- As we get older, our immune systems age, increasing our risk of life threatening infections. Without reliable antibiotics, life expectancy could decline for the first time in modern history.
- If antibiotics become ineffective, common infections could result in hospitalization or even death. Life-saving interventions like cancer treatments and organ transplantation would become more difficult, more often resulting in death. Routine procedures would become hard to perform.
- Without intervention, resistant pathogens could result in 10 million annual deaths by 2050.
- By taking a multi-faceted approach—inclusive of adherence to good stewardship, surveillance and responsible manufacturing practices, as well as an emphasis on prevention and treatment—companies like Pfizer are fighting to help curb the spread.
No, the Syrian civil war is not over. But it might be soon. Time for a recap
- The War in Syria has dropped off the radar, but it's not over (yet)
- This 1-minute video shows how the fronts have moved – and stabilised – over the past 22 months
- Watching this video may leave you both better informed, and slightly queasy: does war need a generic rock soundtrack?
Entrepreneur and author Andrew Horn shares his rules for becoming an assured conversationalist.
- To avoid basing action on external validation, you need to find your "authentic voice" and use it.
- Finding your voice requires asking the right questions of yourself.
- There are 3-5 questions that you would generally want to ask people you are talking to.
SMARTER FASTER trademarks owned by The Big Think, Inc. All rights reserved.